|
Centre for Policy on Ageing | |
 | |
|
Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice | Author(s) | Arnold G Zermansky, Duncan R Petty, David K Raynor |
Journal title | British Medical Journal, vol 323, no 7325, 8 December 2001 |
Pages | pp 1340-1343 |
Keywords | Drugs ; Consultation ; General practice ; Clinical surveys ; Leeds. |
Annotation | A trained pharmacist can conduct clinical medication review of older patients in the general practice setting. Patients aged 65+ from four general practices in Leeds Health Authority who had received at least one drug repeat prescription up to 1 June 1999 were invited to participate. 590 patients (97%) in an intervention group were reviewed by the pharmacist, compared with 233 (44%) in the control group (normal care) reviewed by the GP. Patients seen by the pharmacist were more likely to have changes made to their repeat prescriptions. Monthly drug costs rose in both groups over the year, but the rise was less in the intervention group, equivalent to £61 per patient per year. Intervention patients had a smaller rise in the number of drugs prescribed. There was no evidence that review of treatment by the pharmacist affected practice consultation rates, outpatient consultations, hospital admissions, or death rate. The pharmacist's review resulted in more changes to treatment than normal care and produced an important cost saving, even after the cost of the intervention was deducted. (RH). |
Accession Number | CPA-011219206 A |
Classmark | LLD: LK6: L5: 3G: 88B * |
Data © Centre for Policy on Ageing |
|
...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|